This website uses cookies to enhance the user experience.
I

INHERIT CARBON SOLUTIONS AS927 688 859

Research
Limited company
Otto Ruges vei 43B 1361 ØSTERÅS, Norge

INHERIT CARBON SOLUTIONS AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Chairman of the board
Years since formation
4 years
since Sep 9, 2021
Type
Limited company
VAT registered
Yes
Number of employees
5

Ownership

Number of shares and share classes
422,831
1 share class
Total number of shareholders
12
11 companies, 1 person

Financials

Total operating income 2024
13,956
NOK
Annual total result 2024
-8,541,492
NOK
Total equity 2024
24,140,501
NOK
Last update: Jul 12, 2025

Management

Management / administration

NameRoleShares
Managing Director/CEO
27.2 %
indirectly

Board

NameRoleShares
Chairman-
Board Member-
KV
Board Member
27.2 %
indirectly
Board Member-
Board Member-
Alternate Member-

Others

NameRoleShares
H
HASLESTAD REGNSKAP AS
Accountant-
R
RSM NORGE AS
Auditor-

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO
27.2 %
indirectly
KV
Board Member
27.2 %
indirectly
-
1.17 %
indirectly
-
1.17 %
indirectly
-
1.17 %
indirectly
-
1.17 %
indirectly
Last update: May 6, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
K
KAJA VOSS HOLDING AS
Ordinary shares
115,000
27.2 %
M
Ordinary shares
115,000
27.2 %
Ordinary shares
84,524
19.99 %
E
EQUINOR VENTURES AS
Ordinary shares
51,868
12.27 %
S
STRATEL AS
Ordinary shares
19,355
4.58 %
Ordinary shares
14,567
3.45 %
F
FARVATN VENTURE AS
Ordinary shares
11,688
2.76 %
M
MOMENTUM II AS
Ordinary shares
5,397
1.28 %
H
HONNINGKRUKKEN VENTURES AS
Ordinary shares
2,875
0.68 %
Ordinary shares
1,304
0.31 %
A
ARKWRIGHT X AS
Ordinary shares
870
0.21 %
M
MELLBYESLAGSVOLD AS
Ordinary shares
383
0.09 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year202420232022
Total operating income
13,956
314,600
349,990
Annual Total Result
-8,541,492
-4,249,053
-1,130,939
Total assets
27,784,662
12,843,630
7,232,734
Total liabilities
3,644,161
10,161,717
727,167
Total equity
24,140,501
2,681,913
6,505,567

P&L

Year202420232022
Total operating income
13,956
314,600
349,990
Total operating costs
8,126,551
5,787,036
1,796,215
Operating result
-8,112,595
-5,472,436
-1,446,225
Financial income/costs
1,120,908
26,253
0
Profit before tax
-6,991,687
-5,446,182
-1,446,225
Total tax & extraordinary income/cost
1,549,805
-1,197,129
-315,286
Annual Total Result
-8,541,492
-4,249,053
-1,130,939

Balance overview

Year202420232022
Total fixed assets
102,805
11,616,505
352,676
Total current assets
27,681,857
1,227,125
6,880,058
Total assets
27,784,662
12,843,630
7,232,734
Short term debt
1,644,161
10,161,717
727,167
Long term debt
2,000,000
0
0
Total liabilities
3,644,161
10,161,717
727,167
Contributed capital
38,190,041
8,189,961
7,764,560
Retained earnings
-14,049,539
-5,508,047
-1,258,994
Total equity
24,140,501
2,681,913
6,505,567
Total equity and liabilities
27,784,662
12,843,630
7,232,734

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology